Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mark Tompkins

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Microbiology Spectrum|September 8, 2021
Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent SeraBinh Ha, Samadhan Jadhao, Laila Hussaini, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
A pan-serotype human monoclonal antibody protects against pneumococcal infection by targeting multiple choline binding domain proteinsAnna L McCormick, Behrouz Ghazi Esfahani, Caroline K Page, et al.
Vaccine|September 6, 2024
A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamstersIrene Hoxie, Kirill Vasilev, Jordan J Clark, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2024
Receptor Binding Specificity of a Bovine A(H5N1) Influenza VirusPradeep Chopra, Caroline K Page, Justin D Shepard, et al.
Journal of Virology|November 20, 2015
Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End GameSabine M G van der Sanden, Weilin Wu, Naomi Dybdahl-Sissoko, et al.
Nature|April 16, 2025
Receptor-binding specificity of a bovine influenza A virusPradeep Chopra, Sean D Ray, Caroline K Page, et al.
Virology|January 27, 2007
Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challengeS Mark Tompkins, Yuan Lin, George P Leser, et al.
Journal of Virology|November 15, 2013
Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig modelJon D Gabbard, Daniel Dlugolenski, Debby Van Riel, et al.
Frontiers in Cellular and Infection Microbiology|September 2, 2022
Ferrets as a model for tuberculosis transmissionTuhina Gupta, Naveen Somanna, Thomas Rowe, et al.
Plos Pathogens|March 25, 2016
Genome-wide siRNA Screening at Biosafety Level 4 Reveals a Crucial Role for Fibrillarin in Henipavirus InfectionCeline Deffrasnes, Glenn A Marsh, Chwan Hong Foo, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Microbiology Spectrum|September 8, 2021
Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent SeraBinh Ha, Samadhan Jadhao, Laila Hussaini, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
A pan-serotype human monoclonal antibody protects against pneumococcal infection by targeting multiple choline binding domain proteinsAnna L McCormick, Behrouz Ghazi Esfahani, Caroline K Page, et al.
Vaccine|September 6, 2024
A recombinant N2 neuraminidase-based CpG 1018® adjuvanted vaccine provides protection against challenge with heterologous influenza viruses in mice and hamstersIrene Hoxie, Kirill Vasilev, Jordan J Clark, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2024
Receptor Binding Specificity of a Bovine A(H5N1) Influenza VirusPradeep Chopra, Caroline K Page, Justin D Shepard, et al.
Journal of Virology|November 20, 2015
Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End GameSabine M G van der Sanden, Weilin Wu, Naomi Dybdahl-Sissoko, et al.
Nature|April 16, 2025
Receptor-binding specificity of a bovine influenza A virusPradeep Chopra, Sean D Ray, Caroline K Page, et al.
Virology|January 27, 2007
Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challengeS Mark Tompkins, Yuan Lin, George P Leser, et al.
Journal of Virology|November 15, 2013
Novel H7N9 influenza virus shows low infectious dose, high growth rate, and efficient contact transmission in the guinea pig modelJon D Gabbard, Daniel Dlugolenski, Debby Van Riel, et al.
Frontiers in Cellular and Infection Microbiology|September 2, 2022
Ferrets as a model for tuberculosis transmissionTuhina Gupta, Naveen Somanna, Thomas Rowe, et al.
Plos Pathogens|March 25, 2016
Genome-wide siRNA Screening at Biosafety Level 4 Reveals a Crucial Role for Fibrillarin in Henipavirus InfectionCeline Deffrasnes, Glenn A Marsh, Chwan Hong Foo, et al.
Pageof 10